Validity of the clinical alert on breast cancer
- 28 February 1990
- journal article
- review article
- Published by Elsevier in The American Journal of Surgery
- Vol. 159 (2) , 195-198
- https://doi.org/10.1016/s0002-9610(05)80258-2
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Prediction of Relapse or Survival in Patients with Node-Negative Breast Cancer by DNA Flow CytometryNew England Journal of Medicine, 1989
- Breast Cancer Therapy: Exercising All Our OptionsNew England Journal of Medicine, 1989
- Adjuvant Therapy of Node-Negative Breast CancerNew England Journal of Medicine, 1989
- Prolonged Disease-Free Survival after One Course of Perioperative Adjuvant Chemotherapy for Node-Negative Breast CancerNew England Journal of Medicine, 1989
- Efficacy of Adjuvant Chemotherapy in High-Risk Node-Negative Breast CancerNew England Journal of Medicine, 1989
- A Randomized Clinical Trial Evaluating Tamoxifen in the Treatment of Patients with Node-Negative Breast Cancer Who Have Estrogen-Receptor–Positive TumorsNew England Journal of Medicine, 1989
- A Randomized Clinical Trial Evaluating Sequential Methotrexate and Fluorouracil in the Treatment of Patients with Node-Negative Breast Cancer Who Have Estrogen-Receptor-Negative TumorsNew England Journal of Medicine, 1989
- Effects of Adjuvant Tamoxifen and of Cytotoxic Therapy on Mortality in Early Breast CancerNew England Journal of Medicine, 1988
- Progress against Cancer?New England Journal of Medicine, 1986
- ON THE TREATMENT OF INOPERABLE CASES OF CARCINOMA OF THE MAMMA: SUGGESTIONS FOR A NEW METHOD OF TREATMENT, WITH ILLUSTRATIVE CASES.1The Lancet, 1896